{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T19:07:30Z","timestamp":1793387250797,"version":"4.5.0"},"reference-count":72,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"Eiger"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinics in Liver Disease"],"published-print":{"date-parts":[[2020,8]]},"DOI":"10.1016\/j.cld.2020.04.008","type":"journal-article","created":{"date-parts":[[2020,4,13]],"date-time":"2020-04-13T05:08:58Z","timestamp":1586754538000},"page":"405-419","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"title":["Viral Hepatitis Other than A, B, and C"],"prefix":"10.1016","volume":"24","author":[{"given":"Amanda","family":"Cheung","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Kwo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"12","key":"10.1016\/j.cld.2020.04.008_bib1","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1136\/gut.18.12.997","article-title":"Immunofluorescence detection of new antigen-antibody system (delta\/anti-delta) associated to hepatitis B virus in liver and in serum of HBsAg carriers","volume":"18","author":"Rizzetto","year":"1977","journal-title":"Gut"},{"key":"10.1016\/j.cld.2020.04.008_bib2","series-title":"Zakim and Boyer's hepatology: a textbook of liver disease","first-page":"501","article-title":"Hepatitis D","author":"Heller","year":"2018"},{"issue":"6","key":"10.1016\/j.cld.2020.04.008_bib3","doi-asserted-by":"crossref","first-page":"1870","DOI":"10.1002\/hep.27742","article-title":"Changing hepatitis D virus epidemiology in a hepatitis B virus endemic area with a national vaccination program","volume":"61","author":"Lin","year":"2015","journal-title":"Hepatology"},{"key":"10.1016\/j.cld.2020.04.008_bib4","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1136\/gutjnl-2018-316601","article-title":"Prevalence and burden of hepatitis D virus infection in the global population: a systematic review and meta-analysis","volume":"68","author":"Chen","year":"2019","journal-title":"Gut"},{"issue":"5","key":"10.1016\/j.cld.2020.04.008_bib5","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1093\/infdis\/151.5.925","article-title":"Hepatitis B virus-associated coinfection and superinfection with delta agent: indistinguishable disease with different outcome","volume":"151","author":"Caredda","year":"1985","journal-title":"J\u00a0Infect Dis"},{"issue":"5","key":"10.1016\/j.cld.2020.04.008_bib6","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1093\/infdis\/155.5.931","article-title":"Influence of hepatitis delta virus infection on progression to cirrhosis in chronic hepatitis type B","volume":"155","author":"Fattovich","year":"1987","journal-title":"J\u00a0Infect Dis"},{"issue":"5","key":"10.1016\/j.cld.2020.04.008_bib7","doi-asserted-by":"crossref","first-page":"1629","DOI":"10.1053\/j.gastro.2009.01.052","article-title":"A\u00a028-year study of the course of hepatitis Delta infection: a risk factor for cirrhosis and hepatocellular carcinoma","volume":"136","author":"Romeo","year":"2009","journal-title":"Gastroenterology"},{"issue":"10","key":"10.1016\/j.cld.2020.04.008_bib8","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1093\/jnci\/djs168","article-title":"A\u00a0population-based study of hepatitis D virus as potential risk factor for hepatocellular carcinoma","volume":"104","author":"Ji","year":"2012","journal-title":"J\u00a0Natl Cancer Inst"},{"issue":"6","key":"10.1016\/j.cld.2020.04.008_bib9","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1111\/jvh.13065","article-title":"Hepatitis D virus infection, cirrhosis and hepatocellular carcinoma in the Gambia","volume":"26","author":"Mahale","year":"2019","journal-title":"J\u00a0Viral Hepat"},{"issue":"1","key":"10.1016\/j.cld.2020.04.008_bib10","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1002\/cld.728","article-title":"Update on prevention, diagnosis, and treatment of chronic hepatitis B: AASLD 2018 Hepatitis B guidance","volume":"12","author":"Terrault","year":"2018","journal-title":"Clin Liver Dis (Hoboken)"},{"key":"10.1016\/j.cld.2020.04.008_bib11","author":"World Health Organization"},{"issue":"8531","key":"10.1016\/j.cld.2020.04.008_bib12","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1016\/S0140-6736(87)92090-3","article-title":"Serological response to the hepatitis delta virus in hepatitis D","volume":"1","author":"Aragona","year":"1987","journal-title":"Lancet"},{"issue":"7","key":"10.1016\/j.cld.2020.04.008_bib13","doi-asserted-by":"crossref","first-page":"e101002","DOI":"10.1371\/journal.pone.0101002","article-title":"Anti-HDV IgM as a marker of disease activity in hepatitis delta","volume":"9","author":"Wranke","year":"2014","journal-title":"PLoS One"},{"issue":"5","key":"10.1016\/j.cld.2020.04.008_bib14","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1002\/hep.28772","article-title":"First international external quality assessment for hepatitis delta virus RNA quantification in plasma","volume":"64","author":"Le Gal","year":"2016","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.cld.2020.04.008_bib15","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1111\/apt.13834","article-title":"Noninvasive markers for staging fibrosis in chronic delta hepatitis","volume":"45","author":"Takyar","year":"2017","journal-title":"Aliment Pharmacol Ther"},{"issue":"4","key":"10.1016\/j.cld.2020.04.008_bib16","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1111\/jvh.13235","article-title":"Vibration-controlled transient elastography for the detection of cirrhosis in chronic Hepatitis D infection","volume":"27","author":"Da","year":"2020","journal-title":"J\u00a0Viral Hepat"},{"issue":"9785","key":"10.1016\/j.cld.2020.04.008_bib17","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/S0140-6736(10)61931-9","article-title":"Hepatitis delta virus","volume":"378","author":"Hughes","year":"2011","journal-title":"Lancet"},{"issue":"4","key":"10.1016\/j.cld.2020.04.008_bib18","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1056\/NEJMoa0912696","article-title":"Peginterferon plus adefovir versus either drug alone for hepatitis delta","volume":"364","author":"Wedemeyer","year":"2011","journal-title":"N\u00a0Engl J Med"},{"issue":"3","key":"10.1016\/j.cld.2020.04.008_bib19","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/S1473-3099(18)30663-7","article-title":"Peginterferon alfa-2a plus tenofovir disoproxil fumarate for hepatitis D (HIDIT-II): a randomised, placebo controlled, phase 2 trial","volume":"19","author":"Wedemeyer","year":"2019","journal-title":"Lancet Infect Dis"},{"issue":"2","key":"10.1016\/j.cld.2020.04.008_bib20","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/j.jhep.2017.03.021","article-title":"EASL 2017 clinical practice guidelines on the management of hepatitis B virus infection","volume":"67","year":"2017","journal-title":"J\u00a0Hepatol"},{"issue":"1","key":"10.1016\/j.cld.2020.04.008_bib21","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s12072-015-9675-4","article-title":"Asian-Pacific clinical practice guidelines on the management of hepatitis B: a 2015 update","volume":"10","author":"Sarin","year":"2016","journal-title":"Hepatol Int"},{"issue":"3","key":"10.1016\/j.cld.2020.04.008_bib22","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1111\/j.1478-3231.2009.02140.x","article-title":"Quantitative HBsAg and HDV-RNA levels in chronic delta hepatitis","volume":"30","author":"Zachou","year":"2010","journal-title":"Liver Int"},{"issue":"1","key":"10.1016\/j.cld.2020.04.008_bib23","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1002\/hep.27102","article-title":"Late HDV RNA relapse after peginterferon alpha-based therapy of chronic hepatitis delta","volume":"60","author":"Heidrich","year":"2014","journal-title":"Hepatology"},{"issue":"6","key":"10.1016\/j.cld.2020.04.008_bib24","doi-asserted-by":"crossref","first-page":"1902","DOI":"10.1002\/hep.27357","article-title":"Understanding early serum hepatitis D virus and hepatitis B surface antigen kinetics during pegylated interferon-alpha therapy via mathematical modeling","volume":"60","author":"Guedj","year":"2014","journal-title":"Hepatology"},{"issue":"13","key":"10.1016\/j.cld.2020.04.008_bib25","doi-asserted-by":"crossref","first-page":"2342","DOI":"10.1016\/j.cgh.2015.05.029","article-title":"Association between level of Hepatitis D virus RNA at week 24 of pegylated interferon therapy and outcome","volume":"13","author":"Keskin","year":"2015","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"6","key":"10.1016\/j.cld.2020.04.008_bib26","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1111\/apt.13734","article-title":"HBsAg kinetics in chronic hepatitis D during interferon therapy: on-treatment prediction of response","volume":"44","author":"Niro","year":"2016","journal-title":"Aliment Pharmacol Ther"},{"issue":"2","key":"10.1016\/j.cld.2020.04.008_bib27","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1002\/hep.1840210211","article-title":"Long-term clinical and virological outcome after liver transplantation for cirrhosis caused by chronic delta hepatitis","volume":"21","author":"Samuel","year":"1995","journal-title":"Hepatology"},{"issue":"5","key":"10.1016\/j.cld.2020.04.008_bib28","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1016\/j.jhep.2018.12.022","article-title":"Treating chronic hepatitis delta: the need for surrogate markers of treatment efficacy","volume":"70","author":"Yurdaydin","year":"2019","journal-title":"J\u00a0Hepatol"},{"issue":"Suppl 4","key":"10.1016\/j.cld.2020.04.008_bib29","doi-asserted-by":"crossref","first-page":"S155","DOI":"10.1016\/0168-8278(91)90050-L","article-title":"Hepatitis E virus. Comparison of 'new and Old World' isolates","volume":"13","author":"Reyes","year":"1991","journal-title":"J\u00a0Hepatol"},{"issue":"9835","key":"10.1016\/j.cld.2020.04.008_bib30","doi-asserted-by":"crossref","first-page":"2477","DOI":"10.1016\/S0140-6736(11)61849-7","article-title":"Hepatitis E","volume":"379","author":"Kamar","year":"2012","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.cld.2020.04.008_bib31","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/jvh.12024","article-title":"Hepatitis E: source and route of infection, clinical manifestations and new developments","volume":"20","author":"Scobie","year":"2013","journal-title":"J\u00a0Viral Hepat"},{"issue":"3","key":"10.1016\/j.cld.2020.04.008_bib32","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/j.jhep.2006.09.016","article-title":"Hepatitis E virus (HEV) infection in patients with cirrhosis is associated with rapid decompensation and death","volume":"46","author":"Kumar Acharya","year":"2007","journal-title":"J\u00a0Hepatol"},{"issue":"9","key":"10.1016\/j.cld.2020.04.008_bib33","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1111\/j.1478-3231.2008.01840.x","article-title":"Hepatitis E and pregnancy: understanding the pathogenesis","volume":"28","author":"Navaneethan","year":"2008","journal-title":"Liver Int"},{"issue":"4","key":"10.1016\/j.cld.2020.04.008_bib34","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1007\/s12072-019-09946-3","article-title":"Acute-on-chronic liver failure: consensus recommendations of the Asian Pacific association for the study of the liver (APASL): an update","volume":"13","author":"Sarin","year":"2019","journal-title":"Hepatol Int"},{"issue":"3","key":"10.1016\/j.cld.2020.04.008_bib35","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1002\/hep.24738","article-title":"Hepatitis E virus (HEV)-specific T-cell responses are associated with control of HEV infection","volume":"55","author":"Suneetha","year":"2012","journal-title":"Hepatology"},{"issue":"5","key":"10.1016\/j.cld.2020.04.008_bib36","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1053\/j.gastro.2011.02.050","article-title":"Factors associated with chronic hepatitis in patients with hepatitis E virus infection who have received solid organ transplants","volume":"140","author":"Kamar","year":"2011","journal-title":"Gastroenterology"},{"issue":"4","key":"10.1016\/j.cld.2020.04.008_bib37","first-page":"352","article-title":"Rheumatologic manifestations of hepatic diseases","volume":"32","author":"Fernandes","year":"2019","journal-title":"Ann Gastroenterol"},{"issue":"4","key":"10.1016\/j.cld.2020.04.008_bib38","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1111\/liv.13037","article-title":"Extrahepatic manifestations of hepatitis E virus","volume":"36","author":"Kamar","year":"2016","journal-title":"Liver Int"},{"issue":"4","key":"10.1016\/j.cld.2020.04.008_bib39","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.pan.2015.05.460","article-title":"Frequency and prognosis of acute pancreatitis associated with acute hepatitis E: a systematic review","volume":"15","author":"Haffar","year":"2015","journal-title":"Pancreatology"},{"issue":"5","key":"10.1016\/j.cld.2020.04.008_bib40","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1016\/S1665-2681(19)31434-6","article-title":"Review of the neurological manifestations of hepatitis E infection","volume":"11","author":"Cheung","year":"2012","journal-title":"Ann Hepatol"},{"issue":"6","key":"10.1016\/j.cld.2020.04.008_bib41","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1097\/TP.0b013e318245f14c","article-title":"Hepatitis E virus and the kidney in solid-organ transplant patients","volume":"93","author":"Kamar","year":"2012","journal-title":"Transplantation"},{"issue":"10","key":"10.1016\/j.cld.2020.04.008_bib42","doi-asserted-by":"crossref","first-page":"e13560","DOI":"10.1371\/journal.pone.0013560","article-title":"Profile of acute infectious markers in sporadic hepatitis E","volume":"5","author":"Huang","year":"2010","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.cld.2020.04.008_bib43","doi-asserted-by":"crossref","DOI":"10.1128\/JCM.01056-18","article-title":"Standardization of nucleic acid tests: the approach of the World Health Organization","volume":"57","author":"Baylis","year":"2019","journal-title":"J\u00a0Clin Microbiol"},{"issue":"3","key":"10.1016\/j.cld.2020.04.008_bib44","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1128\/JCM.02343-15","article-title":"Diagnostic performance of five assays for anti-hepatitis E virus IgG and IgM in a large cohort study","volume":"54","author":"Norder","year":"2016","journal-title":"J\u00a0Clin Microbiol"},{"issue":"Pt 3","key":"10.1016\/j.cld.2020.04.008_bib45","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1099\/vir.0.81545-0","article-title":"Putative neutralization epitopes and broad cross-genotype neutralization of Hepatitis E virus confirmed by a quantitative cell-culture assay","volume":"87","author":"Emerson","year":"2006","journal-title":"J\u00a0Gen Virol"},{"issue":"2","key":"10.1016\/j.cld.2020.04.008_bib46","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1111\/j.1365-2559.2007.02756.x","article-title":"The histology of acute autochthonous hepatitis E virus infection","volume":"51","author":"Malcolm","year":"2007","journal-title":"Histopathology"},{"issue":"4","key":"10.1016\/j.cld.2020.04.008_bib47","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1038\/modpathol.2014.147","article-title":"Molecular detection of hepatitis E virus (HEV) in liver biopsies after liver transplantation","volume":"28","author":"Protzer","year":"2015","journal-title":"Mod Pathol"},{"issue":"9","key":"10.1016\/j.cld.2020.04.008_bib48","doi-asserted-by":"crossref","first-page":"e13514","DOI":"10.1111\/ctr.13514","article-title":"Viral hepatitis: guidelines by the American society of transplantation infectious disease community of practice","volume":"33","author":"Te","year":"2019","journal-title":"Clin Transplant"},{"issue":"1","key":"10.1016\/j.cld.2020.04.008_bib49","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1002\/lt.23764","article-title":"Hepatitis E infection in liver transplant recipients","volume":"20","author":"Unzueta","year":"2014","journal-title":"Liver Transpl"},{"issue":"6","key":"10.1016\/j.cld.2020.04.008_bib50","doi-asserted-by":"crossref","first-page":"1418","DOI":"10.1016\/j.jhep.2014.08.047","article-title":"The impact of hepatitis E in the liver transplant setting","volume":"61","author":"Behrendt","year":"2014","journal-title":"J\u00a0Hepatol"},{"issue":"4","key":"10.1016\/j.cld.2020.04.008_bib51","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1002\/lt.22014","article-title":"Treatment of chronic hepatitis E in liver transplant recipients with pegylated interferon alpha-2b","volume":"16","author":"Haagsma","year":"2010","journal-title":"Liver Transpl"},{"issue":"12","key":"10.1016\/j.cld.2020.04.008_bib52","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1056\/NEJMoa1215246","article-title":"Ribavirin for chronic hepatitis E virus infection in transplant recipients","volume":"370","author":"Kamar","year":"2014","journal-title":"N\u00a0Engl J Med"},{"issue":"4","key":"10.1016\/j.cld.2020.04.008_bib53","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1080\/21645515.2015.1008870","article-title":"The development of a recombinant hepatitis E vaccine HEV 239","volume":"11","author":"Li","year":"2015","journal-title":"Hum Vaccin Immunother"},{"issue":"10","key":"10.1016\/j.cld.2020.04.008_bib54","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.1002\/lt.21250","article-title":"Herpes simplex virus hepatitis: an analysis of the published literature and institutional cases","volume":"13","author":"Norvell","year":"2007","journal-title":"Liver Transpl"},{"issue":"10","key":"10.1016\/j.cld.2020.04.008_bib55","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.1002\/lt.21567","article-title":"Detection and diagnosis of herpes simplex virus infection in adults with acute liver failure","volume":"14","author":"Levitsky","year":"2008","journal-title":"Liver Transpl"},{"issue":"1","key":"10.1016\/j.cld.2020.04.008_bib56","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/0002-9343(90)90133-X","article-title":"Varicella hepatitis in the immunocompromised adult: a case report and review of the literature","volume":"88","author":"Patti","year":"1990","journal-title":"Am J Med"},{"issue":"6","key":"10.1016\/j.cld.2020.04.008_bib57","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1097\/00007890-199509270-00019","article-title":"Varicella-zoster virus hepatitis and a suggested management plan for prevention of VZV infection in adult liver transplant recipients","volume":"60","author":"Kusne","year":"1995","journal-title":"Transplantation"},{"issue":"9","key":"10.1016\/j.cld.2020.04.008_bib58","doi-asserted-by":"crossref","first-page":"e13563","DOI":"10.1111\/ctr.13563","article-title":"Vaccination of solid organ transplant candidates and recipients: guidelines from the American society of transplantation infectious diseases community of practice","volume":"33","author":"Danziger-Isakov","year":"2019","journal-title":"Clin Transplant"},{"issue":"1","key":"10.1016\/j.cld.2020.04.008_bib59","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.ejim.2010.07.016","article-title":"Epstein Barr virus hepatitis","volume":"22","author":"Kofteridis","year":"2011","journal-title":"Eur J Intern Med"},{"issue":"7","key":"10.1016\/j.cld.2020.04.008_bib60","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1007\/s10620-014-3029-2","article-title":"Epstein-Barr virus (EBV) related acute liver failure: a case series from the US Acute Liver Failure Study Group","volume":"59","author":"Mellinger","year":"2014","journal-title":"Dig Dis Sci"},{"issue":"3","key":"10.1016\/j.cld.2020.04.008_bib61","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/S1074-7613(00)80622-6","article-title":"EBV persistence in memory B cells in\u00a0vivo","volume":"9","author":"Babcock","year":"1998","journal-title":"Immunity"},{"issue":"9","key":"10.1016\/j.cld.2020.04.008_bib62","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1097\/PAS.0b013e31802ffdd5","article-title":"Epstein-Barr virus hepatitis: diagnostic value of in\u00a0situ hybridization, polymerase chain reaction, and immunohistochemistry on liver biopsy from immunocompetent patients","volume":"31","author":"Suh","year":"2007","journal-title":"Am J Surg Pathol"},{"issue":"5 Pt 1","key":"10.1016\/j.cld.2020.04.008_bib63","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1111\/j.1600-6143.2006.01294.x","article-title":"Post-transplant lymphoproliferative disorders following liver transplantation: incidence, risk factors and survival","volume":"6","author":"Kremers","year":"2006","journal-title":"Am J Transplant"},{"issue":"9","key":"10.1016\/j.cld.2020.04.008_bib64","doi-asserted-by":"crossref","first-page":"e13652","DOI":"10.1111\/ctr.13652","article-title":"Post-transplant lymphoproliferative disorders, epstein-barr virus infection, and disease in solid organ transplantation: guidelines from the American Society of Transplantation Infectious Diseases Community of Practice","volume":"33","author":"Allen","year":"2019","journal-title":"Clin Transplant"},{"issue":"11","key":"10.1016\/j.cld.2020.04.008_bib65","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1086\/652438","article-title":"Cytomegalovirus seroprevalence in the United States: the national health and nutrition examination surveys, 1988-2004","volume":"50","author":"Bate","year":"2010","journal-title":"Clin Infect Dis"},{"issue":"2","key":"10.1016\/j.cld.2020.04.008_bib66","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1097\/00005792-198503000-00003","article-title":"Cytomegalovirus infection in the normal host","volume":"64","author":"Cohen","year":"1985","journal-title":"Medicine (Baltimore)"},{"issue":"10","key":"10.1016\/j.cld.2020.04.008_bib67","doi-asserted-by":"crossref","first-page":"2181","DOI":"10.1111\/j.1600-6143.2011.03618.x","article-title":"Association of cytomegalovirus infection and disease with death and graft loss after liver transplant in high-risk recipients","volume":"11","author":"Bosch","year":"2011","journal-title":"Am J Transplant"},{"issue":"6","key":"10.1016\/j.cld.2020.04.008_bib68","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1097\/TP.0000000000002191","article-title":"The third international consensus guidelines on the management of cytomegalovirus in solid-organ transplantation","volume":"102","author":"Kotton","year":"2018","journal-title":"Transplantation"},{"issue":"21","key":"10.1016\/j.cld.2020.04.008_bib69","doi-asserted-by":"crossref","first-page":"2561","DOI":"10.3748\/wjg.15.2561","article-title":"Human herpesvirus 6 infections after liver transplantation","volume":"15","author":"Abdel Massih","year":"2009","journal-title":"World J Gastroenterol"},{"issue":"9","key":"10.1016\/j.cld.2020.04.008_bib70","doi-asserted-by":"crossref","first-page":"e13518","DOI":"10.1111\/ctr.13518","article-title":"Human herpesvirus 6, 7, and 8 in solid organ transplantation: guidelines from the American society of transplantation infectious diseases community of practice","volume":"33","author":"Pellett Madan","year":"2019","journal-title":"Clin Transplant"},{"issue":"2","key":"10.1016\/j.cld.2020.04.008_bib71","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1016\/j.jaad.2019.03.028","article-title":"Management of Kaposi sarcoma after solid organ transplantation: a European retrospective study","volume":"81","author":"Delyon","year":"2019","journal-title":"J\u00a0Am Acad Dermatol"},{"issue":"12","key":"10.1016\/j.cld.2020.04.008_bib72","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1007\/s11908-019-0709-2","article-title":"The role of emerging and neglected viruses in the etiology of hepatitis","volume":"21","author":"Mrzljak","year":"2019","journal-title":"Curr Infect Dis Rep"}],"container-title":["Clinics in Liver Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1089326120300337?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1089326120300337?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T17:57:14Z","timestamp":1761069434000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1089326120300337"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8]]},"references-count":72,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2020,8]]}},"alternative-id":["S1089326120300337"],"URL":"https:\/\/doi.org\/10.1016\/j.cld.2020.04.008","relation":{},"ISSN":["1089-3261"],"issn-type":[{"value":"1089-3261","type":"print"}],"subject":[],"published":{"date-parts":[[2020,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Viral Hepatitis Other than A, B, and C","name":"articletitle","label":"Article Title"},{"value":"Clinics in Liver Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cld.2020.04.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}